SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Information

The Company’s segment financial information was as follows:

	Year Ended December 31,
	2024
(in millions)	Connected Technology Solutions	Essential Dental Solutions	Orthodontic and Implant Solutions	Wellspect Healthcare	Total
Net sales	1,062	1,454	973	304	3,793
Adjusted cost of products sold (a)	602	565	407	117
Adjusted selling expenses (b)	242	313	301	52
Adjusted G&A expenses (b)	74	74	133	27
Adjusted R&D expenses (c)	74	23	52	10
Segment adjusted operating income	70	479	80	98	727
Reconciling items (income) expense:
Unallocated corporate costs (d)					320
Interest expense, net					69
Other (income) expense, net					(12)
Goodwill and intangible asset impairments					1,014
Restructuring and other costs					53
Amortization of intangibles					216
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations					3
Loss before income taxes					(936)

(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.

(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.

(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.

(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, unallocated professional service fees, and other operating costs which are not assigned to a specific segment.

	Year Ended December 31,
	2023
(in millions)	Connected Technology Solutions	Essential Dental Solutions	Orthodontic and Implant Solutions	Wellspect Healthcare	Total
Net sales	1,169	1,468	1,040	288	3,965
Adjusted cost of products sold (a)	645	560	402	114
Adjusted selling expenses (b)	264	313	305	51
Adjusted G&A expenses (b)	77	94	119	25
Adjusted R&D expenses (c)	82	23	58	11
Segment adjusted operating income	101	478	156	87	822
Reconciling items (income) expense:
Unallocated corporate costs (d)					319
Interest expense, net					81
Other (income) expense, net					9
Goodwill and intangible asset impairments					307
Restructuring and other costs					67
Amortization of intangibles					211
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations					3
Loss before income taxes					(175)

(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.

(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.

(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.

(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, unallocated professional service fees, and other operating costs which are not assigned to a specific segment.

	Year Ended December 31,
	2022
(in millions)	Connected Technology Solutions	Essential Dental Solutions	Orthodontic and Implant Solutions	Wellspect Healthcare	Total
Net sales	1,219	1,427	1,006	270	3,922
Adjusted cost of products sold (a)	631	540	370	109
Adjusted selling expenses (b)	251	301	285	48
Adjusted G&A expenses (b)	80	94	124	27
Adjusted R&D expenses (c)	96	25	34	13
Segment adjusted operating income	161	467	193	73	894
Reconciling items (income) expense:
Unallocated corporate costs (d)					318
Interest expense, net					65
Other (income) expense, net					53
Goodwill and intangible asset impairments					1,287
Restructuring and other costs					14
Amortization of intangibles					209
Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations					3
Loss before income taxes					(1,055)

(a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs.

(b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs.

(c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs.

(d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, unallocated professional service fees, and other operating costs which are not assigned to a specific segment.

Depreciation and Amortization	Year Ended December 31,
(in millions)	2024		2023		2022
Connected Technology Solutions	$	175	$	176	$	172
Essential Dental Solutions	35		33		31
Orthodontic and Implant Solutions	98		97		90
Wellspect Healthcare	19		18		21
All Other (a)	22		19		14
Total	$	349	$	343	$	328

(a) Includes unallocated corporate costs for depreciation and amortization

The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:

(in millions)	December 31, 2023		Provisions and  Adjustments		Amounts Applied		Change in Estimates		December 31, 2024
Connected Technology Solutions	$	13	$	23	$	(25)	$	(2)	$	9
Essential Dental Solutions	17		15		(20)		(1)		11
Orthodontic and Implant Solutions	9		11		(11)		—		9
Wellspect Healthcare	1		5		(2)		(1)		3
All Other	—		3		(2)		—		1
Total	$	40	$	57	$	(60)	$	(4)	$	33

The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:

(in millions)	December 31, 2022		Provisions and  Adjustments		Amounts Applied		Change in Estimates		December 31, 2023
Connected Technology Solutions	$	3	$	18	$	(8)	$	—	$	13
Essential Dental Solutions	4		25		(10)		(2)		17
Orthodontic and Implant Solutions	1		16		(7)		(1)		9
Wellspect Healthcare	—		5		(3)		(1)		1
All Other	—		10		(10)		—		—
Total	$	8	$	74	$	(38)	$	(4)	$	40

Schedule of Net Sales and Long Lived Assets by Geographic Location

The following tables set forth information about the Company’s significant operations by geographic areas, for the years ended December 31, 2024, 2023, and 2022. Net sales reported below represent revenues from external customers in those respective countries based on the destination of shipments.

	Year Ended December 31,
(in millions)	2024		2023		2022
Net sales
United States	$	1,348	$	1,437	$	1,393
Germany	410		431		447
Other Foreign	2,035		2,097		2,082
Total net sales	$	3,793	$	3,965	$	3,922

Property, plant and equipment, net, represents those long-lived assets held by the operating businesses located in the respective geographic areas.

	Year Ended December 31,
(in millions)	2024		2023		2022
Property, plant, and equipment, net
United States	$	210	$	194	$	174
Germany	230		260		275
Sweden	101		105		98
Other Foreign	225		241		214
Total property, plant, and equipment, net	$	766	$	800	$	761

Schedules of Concentration Risk

Customers that accounted for 10% or more of net sales or accounts receivable for the years ended December 31, 2023 and 2022 were as follows:

	Year Ended December 31,
	2023				2022
	% of net sales		% of accounts receivable		% of net sales		% of accounts receivable
Henry Schein, Inc.	14	%	11	%	11	%	15	%
Patterson Companies, Inc.	N/A		10	%	N/A		12	%